What Drug Companies Hide From You

ABC News: "The results of a clinical trial released Monday found that Vytorin did not reduce the buildup of harmful plaque in arteries any better than a much cheaper generic drug.
But the study was completed in April 2006. Typically, results are released in three to six months. Merck and Schering-Plough, the two companies that developed and marketed the drug, withheld test results for 19 months."